Mu‐Chun Li - Concepedia

Author

Mu‐Chun Li

Taichung Veterans General Hospital ORCID

Also Known As

Mu-Chun LI, Mu-Chun Li, Mu‐Chun Li

Publications

562

Citations

H-Index

Concepts

All Affiliations

Taichung Veterans General Hospital National Health Research Institutes National Tsing Hua University Pondicherry University Institute of Biomedical Sciences, Academia Sinica

About

Mu‐Chun Li is an author at Taichung Veterans General Hospital specializing in medicine, pathology, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	177
2	Natural Sciences	1	1	53
3	Biochemistry	1	1	53
4	Biology	1	1	33
5	Biomolecular Engineering	1	1	16

Mu‐Chun Li

Publications

346

Citations

H-Index

Page 1

	Year	Citations
Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme Cheng-Yi Chang, Mu‐Chun Li, Su‐Lan Liao, Journal of Clinical Neuroscience Neuro-oncologyMedicineImmunologyPathologyHigh-grade Gliomas	2005	98
Nuclear Krüppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis Yi–Ju Chen, Chun‐Ying Wu, Chia‐Che Chang, Cancer Biology & Therapy	2008	78
The aberrant expression of cytosolic carbonic anhydrase and its clinical significance in human non-small cell lung cancer Whei-Ling Chiang, Shu-Chen Chu, Shyh-Sheng Yang, Cancer Letters BiochemistryOncogenic AgentNatural SciencesAberrant ExpressionPathology	2002	53
Paralytic ileus in MELAS with phenotypic features of MNGIE Tung‐Ming Chang, Ching‐Shiang Chi, Chi‐Ren Tsai, Pediatric Neurology BiologyParalytic IleusGut BarrierDigestive TractMicrobiome	2004	33
Design of drug-like hepsin inhibitors against prostate cancer and kidney stones Vincent Blay, Mu‐Chun Li, Sunita P. Ho, Acta Pharmaceutica Sinica B	2019	17
The interaction of H. pylori infection and NSAIDs in cyclooxygenase-2 mRNA expression in gastric antral, corpus mucosa, and gastric ulcer. Chun‐Ying Wu, Ming‐Shiang Wu, Chien‐Jen Chen, PubMed	2005	16
Design and synthesis of novel orally selective and type II pan-TRK inhibitors to overcome mutations by property-driven optimization Mu‐Chun Li, Wen‐Hsing Lin, Peichen Wang, European Journal of Medicinal Chemistry Medicinal ChemistryProperty-driven OptimizationMedicineDrug DiscoveryPharmacology	2021	16
Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer Mu‐Chun Li, Mohane Selvaraj Coumar, Shu‐Yu Lin, Journal of Medicinal Chemistry	2023	15
Amyloidosis of medium-sized arteries presenting as perioral mass: A case report Mu‐Chun Li, Guan Chou, Jung‐Ta Chen, Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology Perioral MassVascular SurgeryNeurologyMedium-sized ArteriesNeuropathology	2003	10
Mimicking H3 Substrate Arginine in the Design of G9a Lysine Methyltransferase Inhibitors for Cancer Therapy: A Computational Study for Structure-Based Drug Design Mariasoosai Ramya Chandar Charles, Mu‐Chun Li, Hsing‐Pang Hsieh, ACS Omega	2021	10

Page 1